NuPathe (NASDAQ: PATH) (Acquired) is Profiled in this Database

Updated At 11 Feb, 2010

Partial description of this company

Innovative neuroscience solutions for diseases of the central nervous system including neurological and psychiatric disorders such as migraine, Parkinson\'s disease, schizophrenia, and bipolar disorder

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of NuPathe (NASDAQ: PATH) (Acquired) plus 4768 other startups.

Start Free 7 Day Trial Now

Learn More About NuPathe (NASDAQ: PATH) (Acquired)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation